RxDoctor Payments Data

Bupesh Parashar, MD

Radiation Oncology · New York, NYNPI 1073627287

Payments from drug & device makers

$1,860in general payments, 2019–2025

Across 4 payments — averaging $464.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novocure Inc.$2K
  • Icotec Medical Inc.$41
  • GT Medical Technologies, Inc$14

What the payments were for

  • Consulting fees$1,75094%
  • Travel & lodging$553%
  • Food & beverage$553%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,860 in reported general payments places this provider in the 70th percentile of 397 radiation oncology providers in New York.

See all radiation oncology providers in New York

Medicare billing

Part B allowed, 2024
$399,522
Medicare patients
138
Services billed
1,684

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl31$217

Paid to pharmacies, not to this prescriber.

Other radiation oncology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →